Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001493152-23-043647
Filing Date
2023-12-05
Accepted
2023-12-05 06:01:45
Documents
1

Document Format Files

Seq Description Document Type Size
1 formsc13g.htm SC 13G 95221
  Complete submission text file 0001493152-23-043647.txt   96619
Mailing Address 101 EAST 52ND ST NEW YORK NY 10022
Business Address
HIRSCHMAN ORIN (Filed by) CIK: 0001131362 (see all company filings)

Type: SC 13G

Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Subject) CIK: 0001279704 (see all company filings)

EIN.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-85798 | Film No.: 231465119
SIC: 2834 Pharmaceutical Preparations